Aytekin Oto to Prostate-Specific Antigen
This is a "connection" page, showing publications Aytekin Oto has written about Prostate-Specific Antigen.
Connection Strength
1.339
-
MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer. J Magn Reson Imaging. 2015 Dec; 42(6):1733-9.
Score: 0.442
-
Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer. AJR Am J Roentgenol. 2013 Nov; 201(5):1041-8.
Score: 0.399
-
Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer. J Urol. 2016 12; 196(6):1670-1675.
Score: 0.120
-
Endorectal MRI for risk classification of localized prostate cancer: Radiographic findings and influence on treatment decisions. Urol Oncol. 2016 09; 34(9):416.e15-21.
Score: 0.119
-
Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):378-84.
Score: 0.091
-
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol. 2021 12; 4(6):868-876.
Score: 0.041
-
Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging. Eur Urol Oncol. 2019 05; 2(3):257-264.
Score: 0.036
-
ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer. J Am Coll Radiol. 2018 May; 15(5S):S132-S149.
Score: 0.034
-
ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol. 2017 May; 14(5S):S245-S257.
Score: 0.032
-
MR imaging of the prostate. Radiol Clin North Am. 2014 Jul; 52(4):811-37.
Score: 0.026